HCA - NYSE

HCA Healthcare, Inc.

HCA·NYSE

$363.23

-1.1%

HealthcareMedical - Care Facilities

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$80.58B

EPS28.6200

P/E Ratio12.69

Earnings Date07/24/2026

60.72B

Assets

3Y+16.0%

5Y+28.0%

10Y+80.0%

63.49B

Total Liabilities

3Y+21.0%

5Y+42.0%

10Y+61.0%

-2.77B

Total Equity

-599%

3Y+3696.0%

5Y-196.0%

10Y-51.0%

HCA Healthcare, Inc. Funding & Solvency Profile

HCA · NYSE

Current Assets

Cash & Cash Equivalents1.04B

Net Receivables10.87B

Inventory1.65B

Other Current Assets0.00

Total Current Assets14 B

Non-Current Assets

Property, Plant & Equipment31.14B

Goodwill & Intangible Assets10.29B

Long-Term Investments633.00M

Other Non-Current Assets5.09B

Total Non-Current Assets37 B

Total Assets

60.72B

Financial Health Analysis

Current Ratio

0.83x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Working Capital

-2791000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

22% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

HCA Healthcare, Inc. Balance Sheet

HCA • NYSE

HCA Healthcare, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	1B	1.9B	935M	908M	1.5B	1.8B	621M	502M	732M	646M	741M	566M	414M	705M	373M	411M	312M	465M	393M	634M
Short-Term Investments	0.0	88M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	1B	2B	935M	908M	1.5B	1.8B	621M	502M	732M	646M	741M	566M	414M	705M	373M	411M	312M	465M	393M	634M
Net Receivables	10.9B	10.8B	10B	8.9B	8.1B	7.1B	7.4B	6.8B	6.5B	5.8B	5.9B	5.7B	5.2B	4.7B	4.5B	3.8B	3.7B	3.8B	3.9B	3.7B
Accounts Receivables	10.9B	10.8B	10B	8.9B	8.1B	7.1B	7.4B	6.8B	6.5B	5.8B	5.9B	5.7B	5.2B	4.7B	4.5B	3.8B	3.7B	3.8B	3.9B	3.7B
Inventory	1.7B	1.7B	2B	2.1B	2B	2B	1.8B	1.7B	1.6B	1.5B	1.4B	1.3B	1.2B	1.1B	1.1B	897M	802M	737M	710M	669M
Other Current Assets	0.0	1.9B	2B	1.8B	2B	1.5B	1.3B	1.2B	1.2B	1.1B	1.2B	1.4B	1.2B	1.3B	1.3B	1.8B	1.8B	1.3B	1.2B	1.1B
Total Current Assets	13.6B	16.4B	14.9B	13.6B	13.5B	12.3B	11.2B	10.2B	10B	9.1B	9.2B	8.9B	8B	7.8B	7.2B	6.9B	6.6B	6.3B	6.2B	6.1B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	31.1B	31.5B	29.9B	27.6B	26.2B	25.2B	24.5B	19.8B	17.9B	16.4B	15B	14.4B	13.6B	13.2B	12.8B	11.4B	11.4B	11.5B	11.4B	11.7B
Goodwill	0.0	9.8B	9.6B	9.3B	9.1B	8.2B	7.9B	7.6B	7B	6.3B	6.3B	6B	0.0	0.0	0.0	0.0	2.6B	2.6B	2.6B	2.6B
Intangible Assets	10.3B	323M	339M	359M	403M	369M	330M	342M	359M	374M	393M	399M	5.9B	5.5B	5.3B	2.7B	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	10.3B	10.1B	9.9B	9.7B	9.5B	8.6B	8.3B	8B	7.4B	6.7B	6.7B	6.4B	5.9B	5.5B	5.3B	2.7B	2.6B	2.6B	2.6B	2.6B
Long-Term Investments	633M	1.2B	1.2B	1.2B	886M	810M	564M	594M	617M	542M	610M	659M	569M	619M	649M	1.5B	2B	2.3B	2.4B	2.6B
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	219M	489M	290M	290M	931M	1.2B	914M	592M	476M
Other Non-Current Assets	5.1B	230M	184M	298M	598M	546M	480M	690M	710M	1.1B	1.2B	620M	703M	969M	931M	1.4B	1.5B	1.6B	1.4B	762M
Total Non-Current Assets	47.2B	43.1B	41.3B	38.8B	37.2B	35.2B	33.9B	29B	26.6B	24.7B	23.5B	22.3B	20.8B	20.3B	19.7B	16.9B	17.6B	18B	17.8B	17.6B
Total Assets	60.7B	59.5B	56.2B	52.4B	50.7B	47.5B	45.1B	39.2B	36.6B	33.8B	32.7B	31.2B	28.8B	28.1B	26.9B	23.9B	24.1B	24.3B	24B	23.7B
LIABILITIES
CURRENT LIABILITIES
Total Payables	4.7B	4.7B	4.6B	4.6B	4.5B	3.9B	3.2B	2.9B	2.9B	2.6B	2.4B	2.3B	2.1B	2B	1.8B	1.5B	1.5B	1.4B	1.4B	1.4B
Accounts Payable	4.7B	4.3B	4.2B	4.2B	4.1B	3.5B	2.9B	2.6B	2.6B	2.3B	2.2B	2B	1.8B	1.8B	1.6B	1.5B	1.5B	1.4B	1.4B	1.4B
Other Payables	0.0	419M	382M	371M	361M	343M	325M	308M	299M	283M	277M	255M	252M	235M	232M	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	2.5B	4.5B	4.4B	3.8B	3.9B	3.7B	3.5B	3.4B	3B	3B	2.8B	2.9B	2.9B	2.7B	2.3B	2.1B	2B	2.1B	2.2B	1.9B
Short Term Debt	6.7B	4.7B	2.4B	370M	237M	209M	145M	788M	200M	216M	233M	338M	786M	1.4B	1.4B	592M	846M	404M	308M	293M
Capital Lease Obligations (Current)	0.0	343M	363M	364M	392M	379M	350M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	2.2B	419M	382M	371M	361M	343M	325M	308M	299M	283M	277M	255M	252M	235M	16M	1.6B	1.8B	1.8B	1.4B	0.0
Other Current Liabilities	2.4B	910M	867M	794M	549M	547M	528M	459M	67M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Liabilities	16.4B	15.2B	12.7B	9.9B	9.6B	8.7B	7.8B	7.6B	6.2B	5.8B	5.5B	5.5B	5.7B	6.2B	5.6B	4.3B	4.3B	3.9B	3.8B	3.6B
NON-CURRENT LIABILITIES
Long Term Debt	41.6B	38.3B	37.2B	37.1B	33.8B	30.8B	33.6B	32B	32.9B	31.2B	30.3B	29.1B	27.6B	27.5B	25.6B	27.6B	24.8B	26.6B	27B	28.1B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141M	-1.6B	155M	164M	125M
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7B	1.6B	1.8B	1.8B	1.4B	1B
Other Non-Current Liabilities	3.7B	3.6B	3.4B	3.1B	3.6B	3.4B	2.8B	2.5B	2.6B	2.4B	3B	3.1B	2.5B	2.7B	2.7B	2.6B	3B	2.9B	2.6B	1.3B
Total Non-Current Liabilities	47.1B	43.8B	42.5B	42.6B	39.7B	35.9B	37.9B	34.6B	35.4B	33.6B	33.3B	32.2B	30.1B	30.2B	28.4B	30.4B	27.8B	29.6B	29.8B	30.6B
Capital Lease Obligations	1.9B	2.2B	2.3B	2.7B	2.7B	2.1B	1.5B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	63.5B	59B	55.2B	52.5B	49.3B	44.6B	45.6B	42.1B	41.6B	39.4B	38.8B	37.7B	35.8B	36.4B	33.9B	34.6B	32.1B	33.5B	33.6B	34.1B
SHAREHOLDERS' EQUITY
Common Stock	2M	3M	3M	3M	3M	3M	3M	3M	4M	4M	4M	4M	4M	4M	4M	4M	1M	1M	1M	1M
Additional Paid-In Capital	0.0	0.0	0.0	0.0	0.0	294M	0.0	0.0	0.0	0.0	0.0	0.0	1.4B	1.8B	1.6B	386M	226M	165M	112M	0.0
Retained Earnings	-5.7B	-2.1B	-1.4B	-2.3B	-532M	777M	-2.4B	-4.6B	-6.5B	-7B	-7.3B	-7.6B	-9.4B	-11B	-9.4B	-11.9B	-8.8B	-9.8B	-10.5B	-11.4B
Accumulated Other Comprehensive Income/Loss	-305M	-387M	-425M	-490M	-404M	-502M	-460M	-381M	-278M	-338M	-265M	-323M	-257M	-457M	-440M	-428M	-450M	-604M	-172M	16M
Total Stockholders' Equity	-6B	-2.5B	-1.8B	-2.8B	-933M	572M	-2.8B	-5B	-6.8B	-7.3B	-7.6B	-7.9B	-8.3B	-9.7B	-8.3B	-11.9B	-9B	-10.3B	-10.5B	-11.4B
Total Equity	-2.8B	555M	1.1B	-73M	1.5B	2.9B	-565M	-2.9B	-5B	-5.6B	-6B	-6.5B	-6.9B	-8.3B	-7B	-10.8B	-8B	-9.3B	-9.6B	-10.5B
Minority Interest	3.3B	3.1B	2.8B	2.7B	2.4B	2.3B	2.2B	2B	1.8B	1.7B	1.6B	1.4B	1.3B	1.3B	1.2B	1.1B	1B	995M	938M	907M
SUMMARY
Total Liabilities & Equity	60.7B	59.5B	56.2B	52.4B	50.7B	47.5B	45.1B	39.2B	36.6B	33.8B	32.7B	31.2B	28.8B	28.1B	26.9B	23.9B	24.1B	24.3B	24B	23.7B
Total Investments	633M	1.3B	1.2B	1.2B	886M	810M	564M	594M	617M	542M	610M	659M	569M	619M	649M	1.5B	2B	2.3B	2.4B	2.6B
Total Debt	50.2B	45.2B	41.9B	40.2B	36.7B	33.1B	35.6B	32.8B	33.1B	31.4B	30.5B	29.4B	28.4B	28.9B	27.1B	28.2B	25.7B	27B	27.3B	28.4B
Net Debt	49.2B	43.3B	40.9B	39.3B	35.3B	31.3B	35B	32.3B	32.3B	30.7B	29.7B	28.9B	28B	28.2B	26.7B	27.8B	25.4B	26.5B	26.9B	27.8B
Shares Outstanding	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374	242,736,374

SEC Filings

HCA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	April 30, 2026	April 27, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 29, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 28, 2026	April 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 24, 2026	April 24, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 13, 2026	April 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 20, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 10, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 27, 2026	January 27, 2026	2026	View Filing
8-K 8-K 2025 N/A	October 31, 2025	October 27, 2025	2025	View Filing

Showing 1 to 10 of 610 filings

Related Guides

Blog Categories

Continue your HCA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.